Please login to the form below

New analysis shows emergency hospital admissions for people with Multiple Sclerosis continue to rise

Updated data published by Wilmington Healthcare and the MS Trust highlights need for more preventative care for MS patients

Emergency hospital admissions for people with Multiple Sclerosis (MS) are on the rise and costing the NHS millions; yet many of them could be avoided, according to a new summary of data by healthcare intelligence provider Wilmington Healthcare and the charity, the Multiple Sclerosis (MS) Trust.  

The information, which updates the authors’ previous analysis of English Hospital Episode Statistics (HES) from 2013/14, shows that emergency hospital admissions for people with MS in England increased by 12.7 percent over the two years to 2015/16.
 

According to the latest HES data, there were 26,679 emergency hospital admissions for people with MS in England in 2015/16, compared to 23,665 in 2013/14, and this cost the NHS a total of £46m.  

However, a large proportion of this emergency care was for problems which could have been avoided with proactive, preventative care and earlier diagnosis and intervention in the community.
 

For example, the report found that urinary tract infections accounted for 14 percent of emergency admissions for MS in 2015/16 and they cost £2,639 per patient; while respiratory issues cost the NHS a total of £5.4m.   Overall, admissions for bladder and bowel related issues for people with MS cost £10.4m in 2015/16.
 

The report found that nearly one in five of the 89,030 people living with MS in England were admitted to hospital as an emergency in 2015/16.  The average cost per admission was £1,733 and the average length of stay was 8.2 days.
 

Sue Thomas, CEO of the Commissioning Excellence Directorate for Wilmington Healthcare, said: “Our latest report shows that the problems we highlighted in our original 2013/14 analysis have increased in the past couple of years. A growing number of patients with MS are being admitted to hospital for emergency care; yet many of these admissions could have been avoided with earlier intervention.  

“Preventative care strategies for people with MS must be reviewed in order to tackle problems, such as respiratory and urinary tract infections, at an early stage to try to avert the need for emergency care. This would not only be of huge benefit to patients, it would also reduce pressure on struggling A&E departments.”  

Pam Macfarlane, Chief Executive of the MS Trust, which provides information for people with MS and supports MS specialist services, said: “It is disappointing to see that avoidable emergency hospital admissions for people with MS have continued to rise in 2015/16.
 

“Last November, the MS Trust brought together partners from across the MS sector to publish the MS Forward View consensus. This showed that people with MS need a flexible blend of care, comprising disease modification and also proactive symptom management and neurorehabilitation, delivered by multidisciplinary teams. This is one reason why we are now funding additional MS nurses in areas of the UK where services are the most overstretched. Only with the right specialist and community based support will we reduce the need for emergency hospital care for people with MS.”  


                                                                        Ends

26th April 2017

Share

Tags

Company Details

Wilmington Healthcare

01268 495600

Contact Website

Address:
Beechwood House
2-3 Commercial Way
Christy Close
Southfields
Basildon
SS15 6EF
United Kingdom

Latest content on this profile

HSJ Awards Finalists Announced
2018 HSJ Awards Finalists Announced.
Wilmington Healthcare
HSJ Partnership Awards will showcase pharma’s inspirational joint working projects with the NHS
Health Service Journal (HSJ), the news and information service for all healthcare leaders working in, for, or with the NHS, has expanded and enhanced its Partnership Awards for 2019.
Wilmington Healthcare
How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change
Wilmington Healthcare
Wilmington Healthcare wins first client for new NHS transformation tracker
Product helps pharma identify opportunities and tailor solutions to a changing NHS
Wilmington Healthcare
Wilmington Healthcare appoints new Commercial Director
Healthcare intelligence provider Wilmington Healthcare, which incorporates HSJ, Binley’s, OnMedica and Wellards, has appointed Sue Plant as Commercial Director for MedTech.
Wilmington Healthcare
How can pharma support NHS service change?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, find some answers in NHS England guidance for commissioners
Wilmington Healthcare